Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDYD Bio Limited Ordinary Shares Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2025 | Q2 2025 | N/A | -$0.65 | N/A | N/A | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$0.98 | N/A | N/A | $0 |
| 12/30/2024 | Q4 2024 | N/A | $0.10 | N/A | N/A | $0 |
| 09/29/2024 | Q3 2024 | N/A | $0.54 | N/A | N/A | $0 |
| 06/29/2024 | Q2 2024 | N/A | $4.05 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$5.12 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | $0.16 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
YD Bio Limited Ordinary Shares Earnings: FAQ's
The conference call for YD Bio Limited Ordinary Shares's latest earnings report can be listened to online.
The conference call transcript for YD Bio Limited Ordinary Shares's latest earnings report can be read online.
YD Bio Limited Ordinary Shares (:YDES) has a recorded annual revenue of $510.36 K.
YD Bio Limited Ordinary Shares (:YDES) has a recorded net income of $-1,411,559.YD Bio Limited Ordinary Shares has generated $-0.56 earnings per share over the last four quarters.
YD Bio Limited Ordinary Shares (:YDES) has a price-to-earnings ratio of -14.46 and price/earnings-to-growth ratio is 0.11.